10:1 Stock Split: Multibagger Stock Under Rs 55 Hit Upper Circuit & 52-Week High on January 06; SME Script With Lot Size of 4,000 Shares
The stock gave multibagger returns of 777 per cent from its 52-week low of Rs 5.82 per share.
On Monday, shares of Sudarshan Pharma Industries Ltd hit a 5 per cent upper circuit to Rs 51.05 per share from its previous closing of Rs 48.62 per share. The stock also made a new 52-week high of Rs 51.05 per share while its 52-week low is Rs 5.82 per share. The shares of the company saw a spurt in volume by more than 1.14 times on BSE.
Sudarshan Pharma Industries Limited (SPIL), established in 2008 and headquartered in Mumbai, is a prominent contract manufacturer of generic formulations. Operating across diverse segments, including speciality chemicals, intermediates, APIs, pharmaceutical and formulation generics, and bulk supply, SPIL caters to a wide range of institutions and healthcare organizations. Beyond its contract manufacturing services, SPIL has ventured into branded products through its Vimac Healthcare division. A significant portion of its product portfolio, consisting of 56 out of 96 items, is registered under the "R" trademark. Furthermore, SPIL collaborates with renowned Indian companies and institutional clients, offering contract manufacturing services for pharmaceutical formulations and medicines.
The company intends to acquire 100% of Sudarshan Pharma Industries Private Limited, a Singapore-based wholesale trader of industrial chemicals, for SGD 10,000, aiming to expand its operations in Singapore and surrounding regions. This acquisition does not involve related party transactions as the target entity is wholly owned by Mr. Amar Ashok Vyas. No significant regulatory approvals are required, and the consideration will be paid in cash. Furthermore, the company has successfully acquired a majority stake (51%) in Ishwari Healthcare Private Limited by acquiring 2,09,100 equity shares, making Ishwari Healthcare a subsidiary. Ishwari Healthcare is a private limited company engaged in the manufacturing, processing, and distribution of a wide range of medical and surgical instruments, equipment, and devices, encompassing various aspects of the healthcare industry, including research, development, manufacturing, marketing, and distribution.
DSIJ’s ‘Micro Marvel' service recommends micro-cap stocks with the potential to grow multifold in long run. If this interests you, do download the service details here.
On November 22, 2023, the shares of the company ex-traded sub-division /stock split of the company’s 1 (one) equity share having a face value of R 10 each fully paid-up, into 10 equity shares of the company having a face value of Re 1 each fully paid-up.
The company has a market cap of Rs 1,228 crore and has delivered good profit growth of 37 per cent CAGR over the last 5 years. The stock gave multibagger returns of 777 per cent from its 52-week low of Rs 5.82 per share. Investors should keep an eye on this micro-cap stock.
Disclaimer: The article is for informational purposes only and not investment advice.